Roche: Dividend Policy Remains Unchanged -Spokesman
January 12 2009 - 3:25AM
Dow Jones News
Swiss drugmaker Roche Holding AG (ROG.VX) said Monday its
dividend policy remains unchanged, reiterating statements made a
year ago that it plans to increase its dividend each year over the
next three.
The comments follow a report in the Financial Times that the
Basel-based drugmaker considers foregoing dividend payments this
year to finance the planned takeover of the shares it doesn't
already own in U.S. biotech company Genentech Inc. (DNA).
Roche spokesman Daniel Piller declined to comment on the FT
report, which suggested that Roche plans to raise its bid for
Genentech. Genentech has rejected the current offer as too low.
Company Web Site: www.roche.com
-By Anita Greil, Dow Jones Newswires; +41 43 443 8044 ;
anita.greil@dowjones.com
Click here to go to Dow Jones NewsPlus, a web front
page of today's most important business and market news, analysis
and commentary. You can use this link on the day this article is
published and the following day.